Memory Pharmaceuticals to Announce Third Quarter 2008 Results on Thursday, November 13, 2008
06 Noviembre 2008 - 4:24PM
PR Newswire (US)
MONTVALE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Memory
Pharmaceuticals Corp. (NASDAQ:MEMY) announced today that it will
report its third quarter 2008 financial results on Thursday,
November 13, 2008 before the U.S. financial markets open.
Management will provide a Company update and discuss the third
quarter results during a conference call the same day, at 9:00 a.m.
EST. Investors and other interested parties may access the call as
follows: Date: Thursday, November 13, 2008 Time: 9:00 a.m. EST
Telephone (U.S.): 866.543.6407 Telephone (international):
617.213.8898 Participant Passcode: 22960486 Webcast:
http://www.memorypharma.com/ under the "Investors" section An audio
replay of the conference call will be available from 11:00 a.m. EST
on Thursday, November 13, 2008, until Thursday, November 20, 2008.
To access the replay, please dial 888.286.8010 (U.S.) or
617.801.6888 (international) and enter pass code number 92102882.
An audio replay of the conference call will also be available under
the "Investors" section of the Company's website during the same
period. About Memory Pharmaceuticals Memory Pharmaceuticals Corp.,
a biopharmaceutical company, is focused on developing innovative
drugs for the treatment of debilitating CNS disorders, many of
which exhibit significant impairment of memory and other cognitive
functions, including Alzheimer's disease and schizophrenia. For
additional information, please visit our website at
http://www.memorypharma.com/. DATASOURCE: Memory Pharmaceuticals
Corp. CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249, or
Laura Perry, LMP Investor Relations Inc., +1-646-719-1055, both for
Memory Pharmaceuticals Corp. Web Site: http://www.memorypharma.com/
Copyright
Memory Pharmaceuticals Corp (MM) (NASDAQ:MEMY)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Memory Pharmaceuticals Corp (MM) (NASDAQ:MEMY)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Memory Pharmaceuticals Corp (MM) (NASDAQ): 0 recent articles
Más de Memory Pharmaceuticals (MM) Artículos de Noticias